Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Control of 3'UTR length by alternative cleavage and polyadenylation in cancer

EF 2009-10

Résumé
The process by which normal cells become cancer cells is a highly complex process. The transition from a normal cell to a cancer cell can often be attributed to genetic mutations in proto-oncogenes; however, activation of the protein products of cancer-causing oncogenes sometimes occurs without mutations in DNA. One newly discovered characteristic of cancer cells is that they tend to produce some mRNAs (molecules used as templates to synthesize proteins) with tail-ends called 3' Untranslated Regions (3'UTRs) that are shorter than in normal cells. This change is important because the 3'UTR of mRNAs contain repressive elements that cause decreased protein expression. The shorter mRNAs produced in cancer cells have usually lost 90% of the 3'UTR and express on average 10-times more protein than their longer counterparts. The process of generating mRNAs with these shorter 3'UTRs is called alternative polyadenylation and cleavage (APA). It has been found that mice injected with a short 3'UTR mRNA that codes for an oncogene called IMP-1 develop tumors. On the other hand, mice injected with a corresponding long 3'UTR mRNA coding for IMP-1 remain healthy. Thus, APA-mediated activation of IMP-1 leads to oncogenic transformation without mutations in DNA. I want to understand the molecular events that cause cancer cells to produce these mRNAs with shorter 3'UTRs. Specifically, I plan to identify protein factors found in cancer cells that influence the production of shorter 3'UTR mRNAs. Since the production of shorter 3'UTR mRNAs by cancer cells is not caused by genetic mutations, the process could be reversible. Therefore, understanding the factors involved in APA may lead to new cancer treatments.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
203058
Name
Miura Pedro E
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Control of 3'UTR length by alternative cleavage and polyadenylation in cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
3'-Utr; Alternative Polyadenylation And Cleavage; Cancer Biology; Deep Sequencing; Oncogenes; Oncogenic Transformation; Post-Transcriptional Regulation; Rna-Protein Interactions; Tumor Suppressor Genes
Abstract
The process by which normal cells become cancer cells is a highly complex process. The transition from a normal cell to a cancer cell can often be attributed to genetic mutations in proto-oncogenes; however, activation of the protein products of cancer-causing oncogenes sometimes occurs without mutations in DNA. One newly discovered characteristic of cancer cells is that they tend to produce some mRNAs (molecules used as templates to synthesize proteins) with tail-ends called 3' Untranslated Regions (3'UTRs) that are shorter than in normal cells. This change is important because the 3'UTR of mRNAs contain repressive elements that cause decreased protein expression. The shorter mRNAs produced in cancer cells have usually lost 90% of the 3'UTR and express on average 10-times more protein than their longer counterparts. The process of generating mRNAs with these shorter 3'UTRs is called alternative polyadenylation and cleavage (APA). It has been found that mice injected with a short 3'UTR mRNA that codes for an oncogene called IMP-1 develop tumors. On the other hand, mice injected with a corresponding long 3'UTR mRNA coding for IMP-1 remain healthy. Thus, APA-mediated activation of IMP-1 leads to oncogenic transformation without mutations in DNA. I want to understand the molecular events that cause cancer cells to produce these mRNAs with shorter 3'UTRs. Specifically, I plan to identify protein factors found in cancer cells that influence the production of shorter 3'UTR mRNAs. Since the production of shorter 3'UTR mRNAs by cancer cells is not caused by genetic mutations, the process could be reversible. Therefore, understanding the factors involved in APA may lead to new cancer treatments.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Miura, Pedro E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~